Does BOSENTAN Cause Basal cell carcinoma? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Basal cell carcinoma have been filed in association with BOSENTAN (Tracleer). This represents 0.0% of all adverse event reports for BOSENTAN.
5
Reports of Basal cell carcinoma with BOSENTAN
0.0%
of all BOSENTAN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Basal cell carcinoma From BOSENTAN?
Of the 5 reports, 2 (40.0%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOSENTAN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does BOSENTAN Cause?
Dyspnoea (2,492)
Death (2,388)
Pneumonia (1,064)
Fatigue (1,025)
Headache (962)
Hospitalisation (915)
Malaise (894)
Diarrhoea (840)
Product dose omission issue (798)
Pulmonary arterial hypertension (778)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which BOSENTAN Alternatives Have Lower Basal cell carcinoma Risk?
BOSENTAN vs BOSENTAN\BOSENTAN
BOSENTAN vs BOSUTINIB
BOSENTAN vs BOTOX
BOSENTAN vs BOTOX COSMETIC
BOSENTAN vs BOTULINUM TOXIN NOS